Document is current
Any future updates will be listed below
-
Authors
Li, Jin
Qin, Shukui
Wen, Lu
Wang, Junsheng
Deng, Wenying
Guo, Weijian
Jia, Tongfu
Jiang, Da
Zhang, Guifang
He, Yifu
Ba, Yi
Zhong, Haijun
Wang, Lin
Lin, Xiaoyan
Yang, Jianwei
Zhao, Jun
Bai, Yuxian
Wu, Xiangyuan
Gao, Feng
Sun, Guogui
Wu, Yongjuan
Ye, Feng
Wang, Qiong
Xie, Zhong
Yi, Tienan
Huang, Yong
Yu, Guohua
Lu, Lin
Yuan, Ying
Li, Wei
Liu, Likun
Sun, Yuping
Sun, Ying
Yin, Lifeng
Hou, Zhiguo
-
Funding
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- License Information
-
More Information
Article History
Received: 20 September 2022
Accepted: 20 March 2023
First Online: 5 May 2023
Declarations
:
: The study was approved by the ethics committee of Fudan University Shanghai Cancer Center and Cancer Center of Bayi Hospital, Affiliated to the Nanjing University of Chinese Medicine (81YY-ZLLL-15–0103). All patients provided written informed consent.
: YS, LFY, and ZGH are employees of Jiangsu Hengrui Pharmaceuticals. All other authors declare no conflicts of interest.
: Not applicable.
